News

Bristol Myers Cuts Earnings Outlook As Legacy Drugs Face Generic Erosion
Bristol Myers Squibb & Co (NYSE:BMY) reported second-quarter 2025 revenues of $12.27 billion, beating the consensus of $11.31 ...
Bristol-Myers Squibb raises 2025 revenue guidance by $700M as new launches and partnerships accelerate growth trajectory
Discover Bristol-Myers Squibb's Q2 2025 earnings insights: 17% growth, new partnerships, and raised guidance signal strong performance and a ...
Bristol-Myers Squibb Company (BMY) Q2 2025 Earnings Call Transcript
Bristol-Myers Squibb Company ( NYSE: BMY) Q2 2025 Earnings Conference Call July 31, 2025 8:00 AM ET ...
Zacks Investment Research on MSN5h
Bristol Myers Beats on Q2 Earnings and Sales, Raises '25 Sales View
Bristol-Myers Squibb Company (BMY) reported second-quarter 2025 adjusted earnings per share (EPS) of $1.46, which comfortably ...
Precision Medicine Online1h
BMS Focused on 'Needle-Moving' Oncology Therapies as Opdivo Growth Slows
The firm is leveraging its expertise in the immuno-oncology space to expedite development of newer agents like the bispecific ...
Treasury & Risk59m
New Cash Leadership Office Builds a Working Capital Culture at BMS
Congratulations to Bristol Myers Squibb on winning the 2025 Gold Alexander Hamilton Award in Working Capital Management!
Upstate Business Journal5h
The Motley Fool: ADRs, explained
An ADR is created when a bank buys shares of a foreign company outside the United States and issues a security representing shares of that company. Priced in U.S. dollars, these ADR shares trade just ...